A Science and Technology Blog
Merck’s Ebola vaccine, which underwent phase-3 trial during the 2014-2015 Ebola epidemic in west Africa, has shown 97.5% efficacy in preventing Ebola disease when used during the current epidemic in…
Delhi and Punjab have introduced HPV vaccination and are expanding it, while a few States have shown interest. And the National Technical Advisory Group on Immunisation is considering the introduction…
When regulators become violators, who is to regulate them? That perplexing question is what arises from the damning report of the Parliamentary Standing Committee that investigated alleged irregularities in the…
The Drugs Technical Advisory Board (DTAB) on Friday recommended revoking the ban on pioglitazone — an oral anti-diabetic drug which was banned on June 18. But the DTAB, which was…
There is growing evidence that the ban the Union Health Ministry imposed on June 18 on pioglitazone — a widely used anti-diabetes oral drug — was taken with undue haste…
Published in The Hindu on May 16, 2011 The question whether all human clinical trials undertaken in India are conducted ethically has been answered. The final report of the three-member…
Published in The Hindu on November 6, 2009 When a two-decade-long search for an effective vaccine to prevent HIV infection has been a failure, the pressure to hype and provide…
The spectre of Vioxx, the blockbuster non-steroidal anti inflammatory drug (NSAID), continues to haunt pharmaceutical giant Merck even five years after the drug was withdrawn from the market due to…
